Towards a molecular and neurobiological understanding of mental health and mental illness for the benefit of citizens and patients
This Horizon Europe funding program aimed to significantly advance the molecular and neurobiological understanding of mental health and mental illness. It sought to uncover the complex interactions of genetic, epigenetic, and environmental factors to drive innovative prevention and treatment strategies, ultimately benefiting citizens and patients across Europe and internationally.
Who is Funded
This section details the types of entities and geographical scope eligible for funding, focusing on collaborative, multidisciplinary research aimed at improving mental health outcomes for citizens and patients.
What is Funded
This section outlines the types of projects and thematic areas supported, emphasizing research that contributes to a deeper understanding of mental health conditions, biomarker identification, and the development of new treatments. Projects should cover various stages of the innovation cycle.
Type and Scope of Funding
This section details the financial support provided, specifically highlighting the grant-based funding model and the significant maximum funding amount available per project to foster impactful research.
Conditions and Requirements
This section specifies the critical conditions for applicants and projects, including administrative, financial, and ethical considerations, along with requirements for collaboration and data management.
Application Procedure
This section outlines the procedural steps for submitting proposals and the subsequent evaluation process, providing an overview of how applications are handled and decisions communicated.
Legal Basis
This section identifies the core legal and policy documents that authorize and govern the funding program, ensuring transparency and adherence to established European Union frameworks.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
10,000,000 €
Allocated Budget:
60,000,000 €
Award Channel:
Framework Programme Call
Region:
European Union, United States of America, and other associated countries.
Sectors:
Healthcare, Research and Development
Beneficiaries:
citizens and patients
Application Type:
Consortium Required
Funding Stages:
Basic Research, Applied Research, Experimental Development, Pilot Testing
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Managed By:
European Commission
Website: